Clinical Trial Update: Lenalidomide Plus Melphalan as a Preparative Regimen for Autologous Stem Cell Transplantation in Relapsed Multiple Myeloma: A Phase 1 / 2 Study [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 results for lenalidomide plus melphalan as a preparative regimen for autologous stem cell transplantation in relapsed multiple myeloma have been poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Melphalan (Melphalan)
• Revlimid (lenalidomide)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-05-13